Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of AK139 in adults with moderate-to-severe atopic dermatitis. The trial is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK139

Snippet

Sponsor: Akeso | Conditions: Moderate-to-Severe Atopic Dermatitis | Phase 2 | Status: NOT_YET_RECRUITING